| 1 |
2022 |
Olivia L. Walker, Margaret L. Dahn, Melanie R. Power Coombs, Paola Marcato. The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting, Frontiers in Oncology. 2022; 11: 791696.
https://doi.org/10.3389/fonc.2021.791696 |
| 2 |
2021 |
Weixuan Wang, Changmei Yang, Haiteng Deng. Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition, Cancer Management and Research. 2021; Volume 13: 8887.
https://doi.org/10.2147/CMAR.S331222 |
| 3 |
2024 |
Milan Teraiya, Oleg Krokhin, Vincent C. Chen, Hélène Perreault. Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme, Journal of Proteome Research. 2024; 23: 465.
https://doi.org/10.1021/acs.jproteome.3c00669 |
| 4 |
2022 |
Yunfei Xu, Haoduo Qiao, Shun Yang, Lin Zhou, Yao Zhao, Qing Xu, Shuying Miao, Dun Yuan, Jie Zhao, Ying Liu. 15-Hydroxyprostaglandin Dehydrogenase Is a Predictor of Stroke-Associated Pneumonia, Frontiers in Neurology. 2022; 13: 893624.
https://doi.org/10.3389/fneur.2022.893624 |
